A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
Titel:
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
Auteur:
Manegold, C. van Zandwijk, N. Szczesna, A. Zatloukal, P. Au, J.S.K. Blasinska-Morawiec, M. Serwatowski, P. Krzakowski, M. Jassem, J. Tan, E.H. Benner, R.J. Ingrosso, A. Meech, S.J. Readett, D. Thatcher, N.